Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

Market Open: Futures Fall Tailing Strong US Job Reports

Futures Fall Amid Rate Cut Uncertainty Futures tied to Canada’s main stock index slid on Monday, tracking declines in U.S. markets, as a strong U.S. jobs report erased expectations of interest rate cuts in 2025. It’s a tough morn...
Lyndsay Malchuk | 1 day ago |

A Look into the Future of Chronic Pain Management

An Interview with Innocan Pharma’s CEO, Iris Bincovich. Innocan Pharma is gaining attention for its innovative pain relief solutions — particularly through its slow-release injection technology. This cutting-edge approach delivers synthetic Cannabidi...
Research | 5 days ago |

NervGen Pharma: Proof that NVG-291 works?

It’s arguably a Eureka moment for investors in NervGen Pharma (TSX.V: NGEN) (OTCQB: NGENF). Tantalizing anecdotal “evidence” has just been published that suggests that NervGen’s prospective wonder-drug — NVG-29...
Knox Henderson | December 23, 2024 |

Brianne Gardner's 2025 stock picks

As you will see in the full video above, Brianne Gardner , senior wealth manager at Velocity Investments, Raymond James Canada reviews her past picks from September to see if they are on the money and she gives three new diversified picks for 2025 in healthcare, ener...
Coreena Robertson | December 19, 2024 |

Gold, growth and sustainability in focus for Mandalay Resources

The following is a transcription of the above video, and The Market Online has edited it for clarity . Canadian-based Mandalay Resources (TSX:MND ) has producing assets in Australia and Sweden focused on gold and antimony. CEO Frazer Bourchier joins me here in stud...
Coreena Robertson | November 6, 2024 |

Gold – takeover circus! 1,000% chance with Desert Gold

Why are precious metal prices rising so sharply? For three weeks now, prices for gold and silver have been soaring. On Wednesday, the price of gold reached a record high of US$2,795. The price is being driven by speculation about falling interest rates and the unc...
André Will-Laudien | October 31, 2024 |

Buzz on the Bullboards: Stocks to watch as TSX hits new highs

This week, the TSX experienced a roller-coaster of wins and losses, yet managed to break a record high. In the face of this dynamic trading environment, three companies have stood out for their notable achievements and promising outlooks. When the Clevela...
Jonathon Brown | October 17, 2024 |

Investment expert gives fall stock picks, companies to watch

Brianne Gardner , senior wealth manager at Velocity Investments, Raymond James Canada, recently joined The Market Online to discuss her fall stock picks, companies to watch and her market insights on the financial sector, interest rates and the U.S. election. As y...
Coreena Robertson | October 7, 2024 |

Oil industry trailblazer Sara Akbar discusses her vision for Sonoro

The following is a transcription of the above video, and The Market Online has edited it for clarity . Following up on our recent conversation with Sonoro Energy Ltd. (TSXV:SNV) CEO Greg Renwick, we had the opportunity to spend some time with Director and Chairp...
Lyndsay Malchuk | September 26, 2024 |

NervGen: Are amazing human trial results leaking out?

“We are very excited! We are very, very excited!” So says Dr. Monica Perez, who is running the first human trial for a potential new wonder drug being developed by a tiny but well-financed life sciences start-up, NervGen Pharma Corp. ...
Knox Henderson | July 2, 2024 |
1 2 3 4 5 6 7 8 9 10 ...